Extensive necrosis after injection of hyaluronic acid filler: Case report and review of the literature

Journal of Cosmetic Dermatology

Volumn 10, Issue 3, 2011, Pages 224-231

  Kassir, Ramtin ^a,b,c,d   Kolluru, Aparanjita ^d   Kassir, Martin ^e  

^a Facial Plastic and Reconstructive Surgery   (United States)

^b St Joseph's Wayne Hospital Department of Otolaryngology   (United States)

^c Mona Lisa Cosmetic Surgery Center   (United States)

^d NEW YORK MEDICAL COLLEGE   (United States)

^e Department of Dermatology ^*  (United States)

Author keywords

Face; Hyaluronic acid; Necrosis; Vaso occlusion

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; AMOXICILLIN PLUS CLAVULANIC ACID; CEFALEXIN; CEFTRIAXONE; CLINDAMYCIN; COTRIMOXAZOLE; DALTEPARIN; DESOXIMETASONE; FILLER; GLYCERYL TRINITRATE; HYALURONIC ACID; HYALURONIDASE; HYDROXYAPATITE; LIDOCAINE; LOW MOLECULAR WEIGHT HEPARIN; PETROLATUM; POLYLACTIC ACID; PREDNISONE; PROSTAGLANDIN E1; PSEUDOMONIC ACID; RADIESSE; SILICON; TACROLIMUS; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; VALACICLOVIR;

ADULT; ALLERGIC REACTION; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG MECHANISM; EARLY DIAGNOSIS; EMBOLISM; ERYTHEMA; HUMAN; HYPERBARIC OXYGEN; INJECTION SITE DISCOMFORT; INJECTION SITE NECROSIS; INJECTION SITE REACTION; MALE; PAPULE; PRIORITY JOURNAL; PRURITUS; SKIN BRUISING; SKIN DISCOLORATION; SKIN NECROSIS; SKIN NODULE; SKIN REDNESS; SKIN SWELLING; SUBCUTANEOUS NODULE; THROMBOSIS; URTICARIA; VASCULAR NECROSIS; WOUND HEALING;

ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; CHEEK; COSMETIC TECHNIQUES; HUMANS; HYALURONIC ACID; INJECTIONS, INTRADERMAL; MALE; MIDDLE AGED; NECROSIS;

EID: 80052446623     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2011.00562.x     Document Type: Article

References (27)

1. Brody HJ. Use of hyaluronidase in the treatment of granulomatous hyaluronic acid reactions or unwanted hyaluronic acid misplacement. Dermatol Surg 2005; 31: 893-7.
2. MacReady N. Minimally invasive aesthetic procedures: implications for plastic surgeons. American Society for Aesthetic Plastic Surgery (ASAPS) - The Aesthetic Meeting 2008 [Internet]. Available at: [Accessed on June 30, ].
3. Winkler AA, Chen HH. Injection, facial fillers. [Internet]. Available at: [Accessed on July 7, ].
4. Lee A, Grummer SE, Kriegel D, Marmur E. Hyaluronidase. Dermatol Surg 2010; 36: 1071-7.
5. James SP, Oldinski R, Zhang M, Schwartz H. Hyaluron microcomposite biomaterials. In: SM Krutz ed. UHMWPE Biomaterials Handbook: Ultra High Molecular Weight Polyethylene in Total Joint Replacement and Medical Devices, 2nd edn. Burlington: Elsevier Inc; 2009: pp. 261.
6. Bachmann F, Erdmann R, Hartmann V et al. The spectrum of adverse reactions after treatment with injectable fillers in the glabellar region: results from the injectable filler safety study. Dermatol Surg 2009; 35: 1629-34.
7. Inoue K, Katsujiro S, Matsumoto D et al. Arterial embolization and skin necrosis of the nasal ala following injection of dermal fillers. Plast Reconstr Surg 2008; 121: 127-8.
8. Schanz S, Schippert W, Ulmer A et al. Arterial embolization caused by injection of hyaluronic acid (Restylane). Br J Dermatol 2002; 146: 928-9.
9. Sclafani A, Fagien S. Treatment of injectable soft tissue filler complications. Dermatol Surg 2009; 35: 1672-80.
10. Hirsch RJ, Cohen JL, Carruthers J. Successful management of an unusual presentation of impending necrosis following a hyaluronic acid injection embolus and a proposed algorithm for management with hyaluronidase. Dermatol Surg 2007; 33: 357-60.
11. Hirsch RJ, Lupo M, Cohen JL, Duffy D. Delayed presentation of impending necrosis following soft tissue augmentation with hyaluronic acid and successful management with hyaluronidase. J Drugs Dermatol 2007; 6: 325-8.
12. Cox SE. Clinical experience with filler complications. Dermatol Surg 2009; 35: 1661-6.
13. Silva MT, Curi AL. Blindness and total ophthalmoplegia after aesthetic polymethylmethacrylate injection: case report. Arq Neuropsiquiatr 2004; 62: 873-4.
14. Cohen JL, Brown MR. Anatomic considerations for soft tissue augmentation of the face. J Drugs Dermatol 2009; 8: 13-6.
15. Grunebaum LD, Allemann IB, Dayan S et al. The risk of alar necrosis associated with dermal filler injection. Dermatol Surg 2009; 35: 1635-40.
16. Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg 2008; 34: S92-9.
17. Glaich AS, Cohen JL, Goldberg LH. Injection necrosis of the glabella: protocol for prevention and treatment after use of dermal fillers. Dermatol Surg 2006; 32: 276-81.
18. Hampson N, Atik D. Central nervous system oxygen toxicity during routine hyperbaric toxicity during routing hyperbaric oxygen therapy. Undersea Hyperb Med 2003; 30: 147-53.
19. Sheikh AY, Rollins MD, Hopf HW et al. Hyperoxia improves microvascular perfusion in a murine wound model. Wound Repair Regen 2005; 13: 303-8.
20. Williams RL. Hyperbaric oxygen therapy and the diabetic foot. J Am Paediatr Med Assoc 1997; 87: 279-82.
21. Dimitrijevich SD, Paranjape S, Wilson JR et al. Effect of hyperbaric oxygen on human skin cells in culture and in human dermal and skin equivalents. Wound Repair Regen 1999; 7: 53-64.
22. Conconi MT, Baiguera S, Guidolin D et al. Effects of hyperbaric oxygen on proliferative and apoptotic activities and reactive oxygen species generation in mouse fibroblast 3T3/J2 cell line. J Invest Med 2003; 51: 227-32.
23. Tompach PC, Lew D, Stoll JL. Cell response to hyperbaric oxygen treatment. Int J Oral Maxillofac Surg 1997; 26: 82-6.
24. Kairuz E, Upton Z, Dawson MA et al. Hyperbaric oxygen stimulates epidermal reconstruction in human skin equivalents. Wound Repair Regen 2007; 15: 266-74.
25. Broussard CL. Hyperbaric oxygenation and wound healing. J Vasc Nurs 2004; 22: 42-8.
26. Latham E, Hare MA, Neumeister M. Hyperbaric oxygen therapy: enhancement of healing in selected problem wounds. [Internet]. Available at: [Accessed on May 19, 2010].
27. Gladstone H, Cohen JL. Adverse effects when injecting facial fillers. Semin Cutan Med Surg 2007; 26: 34-9.